Learn More
Medchemexpress LLC 4-Hydroxymethylpyrazole | 25222-43-9 | 99.7% | 98.11 | 100 G

Supplier: Medchemexpress LLC HY33914100G
4-Hydroxymethylpyrazole is the primary metabolite of Fomepizole, produced through hepatic oxidative metabolism. It exhibits a plasma concentration positively correlated with the administered dosage of Fomepizole and has a relatively short half-life. This compound demonstrates inhibitory effects on alcohol dehydrogenase (ADH) in humans and monkeys, though its in vivo impact is negligible due to a significantly higher inhibition constant compared to Fomepizole. It is intended for research use only.
- Primary metabolite of Fomepizole
- Produced through hepatic oxidative metabolism
- Exhibits plasma concentration positively correlated with administered dosage
- Relatively short half-life
- Demonstrates inhibitory effects on alcohol dehydrogenase (ADH)
- For research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.